Skip to main content

Table 2 Laboratory results at baseline and during follow up visits

From: Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study

  Visit 1 Visit 2 Visit 3
Median (IQR) Median (IQR) Median (IQR)
FXIIIa (%) 96.5 (77.7–115.0) 100.0 (85.0–113.5) 101 (86.5–121.5)
WBC (Gpt/L) 7.6 (5.9–9.5) 8.1 (6.5–11.1) 7.3 (5.9–9.2)
Hb (mmol/L) 8.4 (7.8–9.1) 8.4 (7.5–8.6) 8.1 (7.7–8.8)
PLT (Gpt/L) 307 (248–395) 312 (288–382) 302 (260–366)
Ferritin (ng/mL) 46.3 (21.9–146.0) 32.6 (11.9–55.6) 34 (14.7–93.8)
Transf. sat. (%) 17.7 (9.3–21.0) 17.9 (9.6–25.8) 19.4 (13.1–29.6)
CRP (mg/L) 13.1 (5.6–15.7) 4.4 (1.7–14.8) 1.3 (0.8–7.5)
Calprotectin (µg/g) 374.0 (98.0–1967.0) 272 (81.9–1336.2) 211 (65.5–522.5)
Thrombin Time (s) 14.6 (13.9–15.5) 14.8 (13.9–15.6) 14.9 (14.5–16.0)
Antithrombin (%) 104.0 (94.0–110.0) 98.0 (92.5–113.0) 101.0 (91.5–107.0)
Fibrinogen (g/L) 3.7 (2.9–4.4) 3.5 (2.4–3.9) 3.5 (2.4–4.0)
D–Dimer (µg/L) 199.0 (94.2–377.0) 164.0 (92.0–408.5) 129.0 (86.0–252.0)